F15c_Diploma_2377_002_20-200907-CER-RD_001-B66034612<\/a><\/p>","protected":false},"excerpt":{"rendered":"El centro de I+D de Embryotools ha recibido el apoyo del CDTI para llevar a cabo otro proyecto innovador cuyo objetivo es estudiar nuevas estrategias para prevenir o reducir la prevalencia de anomal\u00edas cromos\u00f3micas en las primeras etapas del desarrollo embrionario. F15c_Diploma_2377_002_20-200907-CER-RD_001-B66034612<\/p>\n","protected":false},"author":70,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"image","meta":{"footnotes":""},"categories":[13,173],"tags":[],"class_list":["post-21221","post","type-post","status-publish","format-image","hentry","category-about-us","category-in-the-news","post_format-post-format-image"],"yoast_head":"\n
Nuestro centro de I+D recibe soporte del CDTI para estudiar estrategias que prevengan la prevalencia de anomalias cromos\u00f3micas - Embryotools<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Nuestro centro de I+D recibe soporte del CDTI para estudiar estrategias que prevengan la prevalencia de anomalias cromos\u00f3micas - Embryotools\" \/>\n<meta name=\"twitter:description\" content=\"El centro de I+D de Embryotools ha recibido el apoyo del CDTI para llevar a cabo otro proyecto innovador cuyo objetivo es estudiar nuevas estrategias para prevenir o reducir la prevalencia de anomal\u00edas cromos\u00f3micas en las primeras etapas del desarrollo embrionario. F15c_Diploma_2377_002_20-200907-CER-RD_001-B66034612\" \/>\n<meta name=\"twitter:creator\" content=\"@embryotools\" \/>\n<meta name=\"twitter:site\" content=\"@embryotools\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paco Gibert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\"},\"author\":{\"name\":\"Paco Gibert\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#\\\/schema\\\/person\\\/386a367a590f99476a8702285aeaf403\"},\"headline\":\"Nuestro centro de I+D recibe soporte del CDTI para estudiar estrategias que prevengan la prevalencia de anomalias cromos\u00f3micas\",\"datePublished\":\"2020-09-14T06:51:17+00:00\",\"dateModified\":\"2020-09-14T15:20:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\"},\"wordCount\":146,\"publisher\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/#organization\"},\"articleSection\":[\"About us\",\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\",\"url\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\",\"name\":\"Nuestro centro de I+D recibe soporte del CDTI para estudiar estrategias que prevengan la prevalencia de anomalias cromos\u00f3micas - Embryotools\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/#website\"},\"datePublished\":\"2020-09-14T06:51:17+00:00\",\"dateModified\":\"2020-09-14T15:20:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/embryotools.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our R&D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#website\",\"url\":\"https:\\\/\\\/embryotools.com\\\/\",\"name\":\"Embryotools\",\"description\":\"for better results\",\"publisher\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/embryotools.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#organization\",\"name\":\"Embryotools\",\"url\":\"https:\\\/\\\/embryotools.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/embryotools.com\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/embryotools_logo_trans_500-2.png\",\"contentUrl\":\"https:\\\/\\\/embryotools.com\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/embryotools_logo_trans_500-2.png\",\"width\":250,\"height\":59,\"caption\":\"Embryotools\"},\"image\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/embryotools\",\"https:\\\/\\\/x.com\\\/embryotools\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/embryotools\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#\\\/schema\\\/person\\\/386a367a590f99476a8702285aeaf403\",\"name\":\"Paco Gibert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g\",\"caption\":\"Paco Gibert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nuestro centro de I+D recibe soporte del CDTI para estudiar estrategias que prevengan la prevalencia de anomalias cromos\u00f3micas - Embryotools","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/","twitter_card":"summary_large_image","twitter_title":"Nuestro centro de I+D recibe soporte del CDTI para estudiar estrategias que prevengan la prevalencia de anomalias cromos\u00f3micas - Embryotools","twitter_description":"El centro de I+D de Embryotools ha recibido el apoyo del CDTI para llevar a cabo otro proyecto innovador cuyo objetivo es estudiar nuevas estrategias para prevenir o reducir la prevalencia de anomal\u00edas cromos\u00f3micas en las primeras etapas del desarrollo embrionario. F15c_Diploma_2377_002_20-200907-CER-RD_001-B66034612","twitter_creator":"@embryotools","twitter_site":"@embryotools","twitter_misc":{"Escrito por":"Paco Gibert","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/#article","isPartOf":{"@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/"},"author":{"name":"Paco Gibert","@id":"https:\/\/embryotools.com\/#\/schema\/person\/386a367a590f99476a8702285aeaf403"},"headline":"Nuestro centro de I+D recibe soporte del CDTI para estudiar estrategias que prevengan la prevalencia de anomalias cromos\u00f3micas","datePublished":"2020-09-14T06:51:17+00:00","dateModified":"2020-09-14T15:20:56+00:00","mainEntityOfPage":{"@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/"},"wordCount":146,"publisher":{"@id":"https:\/\/embryotools.com\/#organization"},"articleSection":["About us","Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/","url":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/","name":"Nuestro centro de I+D recibe soporte del CDTI para estudiar estrategias que prevengan la prevalencia de anomalias cromos\u00f3micas - Embryotools","isPartOf":{"@id":"https:\/\/embryotools.com\/#website"},"datePublished":"2020-09-14T06:51:17+00:00","dateModified":"2020-09-14T15:20:56+00:00","breadcrumb":{"@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/embryotools.com\/"},{"@type":"ListItem","position":2,"name":"Our R&D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities"}]},{"@type":"WebSite","@id":"https:\/\/embryotools.com\/#website","url":"https:\/\/embryotools.com\/","name":"Embryotools","description":"for better results","publisher":{"@id":"https:\/\/embryotools.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/embryotools.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/embryotools.com\/#organization","name":"Embryotools","url":"https:\/\/embryotools.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/embryotools.com\/#\/schema\/logo\/image\/","url":"https:\/\/embryotools.com\/wp-content\/uploads\/2017\/01\/embryotools_logo_trans_500-2.png","contentUrl":"https:\/\/embryotools.com\/wp-content\/uploads\/2017\/01\/embryotools_logo_trans_500-2.png","width":250,"height":59,"caption":"Embryotools"},"image":{"@id":"https:\/\/embryotools.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embryotools","https:\/\/x.com\/embryotools","https:\/\/www.linkedin.com\/company\/embryotools"]},{"@type":"Person","@id":"https:\/\/embryotools.com\/#\/schema\/person\/386a367a590f99476a8702285aeaf403","name":"Paco Gibert","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g","caption":"Paco Gibert"}}]}},"_links":{"self":[{"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/posts\/21221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/users\/70"}],"replies":[{"embeddable":true,"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/comments?post=21221"}],"version-history":[{"count":5,"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/posts\/21221\/revisions"}],"predecessor-version":[{"id":22973,"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/posts\/21221\/revisions\/22973"}],"wp:attachment":[{"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/media?parent=21221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/categories?post=21221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/tags?post=21221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}